AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,815,676 | -36.4% | 2,409,289 | +1.7% | 12.25% | -28.7% |
| Q2 2023 | $39,042,585 | +70.6% | 2,369,089 | -5.2% | 17.18% | +46.6% |
| Q1 2023 | $22,889,355 | +27.1% | 2,498,838 | -0.6% | 11.72% | +14.0% |
| Q4 2022 | $18,006,720 | +38.5% | 2,514,905 | -3.1% | 10.28% | +29.3% |
| Q3 2022 | $13,000,000 | +106.2% | 2,594,760 | +0.4% | 7.95% | +109.5% |
| Q2 2022 | $6,305,000 | -61.2% | 2,584,090 | +8.7% | 3.80% | -49.9% |
| Q1 2022 | $16,237,000 | -12.8% | 2,377,290 | +3.1% | 7.58% | -2.0% |
| Q4 2021 | $18,625,000 | – | 2,305,017 | – | 7.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |